Fam Cancer. 2012 Jun 9. [Epub ahead of print]
Showing posts with label mortality rates. Show all posts
Showing posts with label mortality rates. Show all posts
Wednesday, June 20, 2012
paywalled: Causes of death of mutation carriers in Finnish Lynch syndrome families.
Fam Cancer. 2012 Jun 9. [Epub ahead of print]
add your opinions
extracolonic cancers
,
Lynch Syndrome
,
mortality rates
,
surveillance
Wednesday, April 11, 2012
health media: Cancer Care Costs Higher in U.S. Than Europe, But Survival Longer - MedicineNet
Cancer Care Costs Higher in U.S. Than Europe, But Survival Longer - MedicineNet
MONDAY, April 9 (HealthDay News) -- The United States spends more on health care than any other country, but those high costs may be paying off in cancer survival, a new report suggests.
U.S. cancer patients often live almost two years longer than similar patients in Europe, arguing for the dollar value of care given, researchers say.
However, Dr. Otis Brawley, the chief medical officer and executive vice president at the American Cancer Society, who was not involved in the study, said that "this paper has a huge fatal flaw in it."
"When you look at survival from time of diagnosis to time of death and you have a screened population that has a lot of diagnoses, you're filling that population with people who don't need treatment and because they are over-diagnosed, they have very long survival," he added.
These researchers attribute increased survival to the treatment, when it is really over-diagnosis, Brawley said. "So they are looking at a bunch of wasted, unnecessary treatment and then saying it was money well spent," he said.
"You don't look at survival rates -- this is a classic misuse of survival rates," Brawley said. "You have to look at death rates for each disease and not survival rates. The measurement should not be expense versus survival -- it should be expense versus mortality rate."
On that scale, the United States does well for some cancers and as well as they do in most of Europe for others, he said. "Mortality rates for breast and colon cancer are close to the mortality rates in Europe, but that may include the effect of over-treatment," Brawley said.
The report was published in the April issue of Health Affairs.
For the study, Tomas Philipson, the chair in public policy at the University of Chicago, and colleagues looked at cancer care in the United States and in 10 European countries from 1983 to 1999.
The investigators found that for most cancers, U.S. patients lived longer than Europeans. Americans lived an average of 11.1 years after diagnosis, compared with 9.3 years for Europeans, they said.
When the authors translated survival data to dollars, they found those extra years were worth $598 billion, which is an average of $61,000 per cancer patient.
The value of these survival gains was highest for prostate cancer ($627 billion) and breast cancer ($173 billion), the findings indicated.
To put a monetary value on survival, the researchers used a "statistical-life concept." In many such studies, they said, estimates are based on how much income a person would exchange for a lower risk of mortality.
"Our findings bear on the larger question of whether higher U.S. health care spending is worth it, suggesting -- although not confirming -- that it is," the researchers wrote.
"Further research is required to examine the drivers of spending and their effects on outcomes, including assessing the relative contributions of treatments, screening, the skill of health care personnel and other factors in improving patient outcomes," they concluded.
On the larger issue of the costs of cancer treatment, Brawley said that "we spend money in an irrational way. We harm people by over-treating them and over-treatment costs money."
Many patients are getting treatments that cause harm, but don't really prolong life, Brawley said. It's hard for a doctor to tell a patient there is nothing that can be done.
"That is the kind of thing doctors need to be developing skills in -- it's an emotional hurdle to say 'I can't stop this,'" he said.
Many patients think that giving up is admitting defeat, and want to be treated even if the treatment will do more harm than good, Brawley said.
"We all need to take a step back and take a look at reality and ask whether the patient stands a good chance of benefiting from a particular treatment. If there aren't benefits, then we ought to, perhaps, stop," he said.
"Instead of talking about rationing care, we need to talk about the rational use of care," Brawley added.
add your opinions
cancer care systems
,
cancer outcomes
,
data
,
Europe
,
mortality rates
,
overtreatment
,
survival rates
,
U.S.
Wednesday, March 14, 2012
interactive: First Ever Local Area Health System Scorecard Finds Significant Differences in Access, Costs, Quality, and Outcomes Within States and Among Nation's Biggest Cities
First Ever Local Area Health System Scorecard Finds Significant Differences in Access, Costs, Quality, and Outcomes Within States and Among Nation's Biggest Cities:
In the first scorecard measuring how 306 local U.S. areas are doing on key health care indicators such as insurance coverage, preventive care, and mortality rates, researchers at The Commonwealth Fund found significant differences between the best- and worst-performing localities.
add your opinions
hospital comparisons
,
mortality rates
,
u.s. healthcare systems
Tuesday, March 13, 2012
open access: Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario (Canada) Hospitals, March 14, 2012 — JAMA
Blogger's Note: universal healthcare system, this study included colorectal cancer patients, comparisons between Canadian/U.S. systems, note authors' affiliations
Association of Hospital Spending Intensity With Mortality and Readmission Rates in Ontario Hospitals, March 14, 2012
"Our objective was to assess whether acute care patients admitted to Canadian hospitals that treat patients more intensively (and at higher cost) have lower mortality and readmissions and higher quality of care.......We studied 4 common conditions that have moderate to high incidence and mortality, that can be validly ascertained using health administrative data, and for which treatment follows relatively standard protocols. "
Design Overview
We undertook a longitudinal cohort
study of patients hospitalized with selected acute clinical conditions
in Ontario, Canada,
and assessed the content, quality, and outcomes
with respect to “exposure” to the index hospital's medical spending
intensity.
Medical intensity is defined as the quantity of
medical care provided overall to similarly ill patients and is a marker
of
a hospital's propensity to treat similarly ill
patients more (or less) intensively. It reflects the component of
spending
variation attributable to practice style rather
than to differences in illness or price.
Because sicker patients use more
services, higher-spending hospitals may appear to have worse outcomes,
in part because patients
are more severely ill. We used several
techniques to remove this potential “reverse causality,” as in previous
work.1,2,3,4COMMENT
We found that higher hospital spending
intensity was associated with better survival, lower readmission rates,
and better
quality of care for seriously ill, hospitalized
patients in Ontario in a universal health care system with more
selective
access to medical technology. Higher-spending
hospitals were higher-volume teaching or community hospitals with
high-volume
or specialist attending physicians and having
specialized programs, such as regional cancer centers, and specialized
services,
such as on-site cardiac catheterization, cardiac
surgery, and diagnostic imaging facilities. The study also points to
plausible
mechanisms through which higher spending may be
associated with better outcomes.
Benefits appeared early, suggesting an
acute-phase hospital effect. For acute conditions, timely access to
preoperative and
in-hospital specialist care, skilled nursing staff,
rapid response teams, cardiac high-technology services, and regional
cancer
centers, all found in the higher-spending systems,
are related to better outcomes.21,27,34,35,36,37,38,39 These systems also provided consistently, but not strikingly, higher levels of evidence-based care and collaborative ambulatory
care, both shown to improve care.22,23,40 Higher spending on evidence-based services delivered in the acute phase of care for severely ill hospitalized patients—by
far the largest component of spending for our cohorts—is indeed likely to be beneficial.
It would be facile to interpret this
study as demonstrating that higher spending is causally related to
better outcomes and
that providing more money to lower-spending
hospitals would necessarily improve their outcomes. Higher-spending
hospitals
differed in many ways, such as greater use of
evidence-based care, skilled nursing and critical care staff, more
intensive
inpatient specialist services, and high technology,
all of which are more expensive.
To place the study in context, the United
States has a 3- to 4-times higher per capita supply of specialized
technology, such
as computed tomography and magnetic resonance
imaging scanners, but a similar supply of acute care beds and nurses.41 Ontario 2001 population rates of cardiac testing and revascularization lagged behind corresponding 1992 US rates and paralleled
the supply of cardiologists and catheterization facilities.42,43,44
It is therefore possible that Canadian hospitals, with fewer
specialized resources, selective access to medical technology,
and global budgets, are using these resources more
efficiently, especially during the inpatient episode for care-sensitive
conditions.45,46 Canada's health care expenditures per capita are about 57% of those in the United States.47
At this spending level, there might still be a positive association
between spending and outcomes. For example, the same-day
PCI rate for patients with AMI in low-intensity
hospitals in 2008 was 3.5%, leaving room for improvement. This pattern
is
consistent with studies in the United States
showing a positive association between spending and outcomes among
low-intensity
hospitals or regions but no association at average
or higher intensity levels.5,6
Strengths of the study include the
population-based, longitudinal cohort design; the consistency of
findings across cardiac,
cancer, medical, and surgical patients; the
examination of plausible clinical mechanisms whereby higher intensity
may be associated
with better outcomes; and the examination of
readmissions. The “look-back” (EOL-EI) and “look-forward” (AC-EI)
measures of
spending intensity were highly correlated and
produced similar findings, as in US studies.2
Several limitations should be considered.
Because the design precludes strong inferences about causation, we
cannot know which
components of care may have led to better outcomes.
In observational studies, comparisons of exposure groups may be biased
because of unobserved selection bias.13
It is unlikely that the findings are the result of unmeasured case mix,
because patients in higher-spending hospitals had
similar or higher illness severity at admission,
which would, if anything, bias toward finding worse outcomes. We cannot
rule
out the possibility that higher-intensity hospitals
coded more aggressively, but there is less incentive to do so in a
system
with global hospital budgets. Although admission
severity would be determined more accurately using clinical detail from
medical
charts, previous work has shown high concordance
between risk-adjusted hospital outcomes using chart and administrative
data.48,49 Canadian data distinguish between comorbidities present at admission and complications, leading to improved admission severity
coding. The EOL-EI has been critiqued for the purpose of estimating hospital efficiency50,51 but is used here simply to distinguish high- and low-intensity hospitals, as in other US studies.1,2,3,4
The findings may not generalize to chronic conditions, for which
avoiding exacerbations of disease that lead to hospitalization
through coordinated ambulatory care is key. The
findings also may not generalize to jurisdictions in which hospital
resources
are more abundant and are used in cost-effective as
well as cost-ineffective ways, leading to inefficiency.45,46
This study shows that in Ontario, a
province with global hospital budgets and fewer specialized health care
resources than
the United States, outcomes following an acute
hospitalization are positively associated with higher hospital spending
intensity.
Higher spending intensity, in turn, is associated
with greater use of specialists, better patient care, and more use of
advanced
procedures. These results suggest that it is
critical to understand not simply how much money is spent but whether it
is spent
on effective procedures and services.
pdf file:
http://jama.ama-assn.org/content/307/10/1037.full.pdf
pdf file:
http://jama.ama-assn.org/content/307/10/1037.full.pdf
add your opinions
Canada
,
costs
,
mortality rates
,
Ontario
,
outcomes
,
quality of care
,
readmission rates
,
universal healthcare system
Thursday, January 19, 2012
US Deaths Resulting From Inpatient Surgery Decline
"January 18, 2012 — The number of surgical procedures performed in the United States increased between 1996 and 2006, whereas inpatient postsurgical deaths within 30 days of admission dropped significantly, according to a national, population-level analysis published (abstract) in the February issue of Surgery....."
".....In 2006, more patients had sepsis or pneumonia than in 1996, and the absolute number of deaths resulting from complications increased. However, the failure-to-rescue rate declined during the study period for both groups (sepsis, from 18.69% to 14.03%; pneumonia, from 8.54% to 7.34%). Meanwhile, the number of deaths resulting from deep venous thrombosis or pulmonary embolism, upper gastrointestinal bleeding, and shock declined during the study period.
Overall, the number of patients with 1 to 5 complications increased, but the failure-to-rescue rate for patients with an identified complication decreased from 12.10% to 9.84% (P < .001)
"The decline in the number of deaths may have occurred through reduced mortality of individual procedures, reductions in the volume of high-risk procedures, and the rescue of patients who had a complication," the authors write.
They estimate that 51,000 fewer people died in 2006 than would have with the 1996 mortality rate. However, they also note that some portion of the decline in mortality "may represent the effect of premature discharge as opposed to an actual improvement in survival." Data were not linked across admissions, and a patient discharged postoperatively who was later readmitted with a complication and died would not be counted as a death in this study."
add your opinions
mortality rates
,
surgery
Wednesday, May 05, 2010
Cervical, Uterine Corpus, and Ovarian Cancer Mortality in Greece During 1980 to 2005: A Trend Analysis
"The increasing trend of uterine corpus and ovarian cancer mortality in older women suggests that development of well-organized tertiary centers for the implementation of modern therapeutic modalities is urgently needed."
add your opinions
Greece
,
mortality
,
mortality rates
Subscribe to:
Posts
(
Atom
)